This is a cross-sectional, single-center observational study conducted from October 2020 to March 2021 in Ile de France at the infectious disease of CHU Bichat (PrEP and CeGIDD(Free Center for Information, Screening and Diagnosis of Infections by Human Immunodeficiency Viruses, Viral Hepatitis and Sexually Transmitted Infections) consultation). It concerns adult subjects of male or transgender sex, of MSM (men having sex with men) or bi-sexual orientation. The data are collected by self-questionnaire evaluating the consumption of Chemsex (drug use in a sexual context) over the last 12 months, the existence or not of addiction treatment, the history of STIs (sexually transmitted infections) and adherence to PrEP (for subjects taking PrEP) during the last sexual intercourse (ANRS questionnaire, used in the PREVENIR study).
Study Type
OBSERVATIONAL
Enrollment
100
self-questionnaire assessing Chemsex's (drug use in a sexual context) consumption over the last 12 months
SMIT - Hôpital Bichat
Paris, France
compare in an MSM and transgender population, the use of Chemsex depending on whether or not PrEP is taken
Time frame: inclusion
Reported adherence to PrEP
Time frame: inclusion
The existence or not of psychological comorbidity and the existence of addictological care
Time frame: inclusion
The number of sexually transmitted infections at inclusion
Time frame: inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.